Terumo : Announces Change of Executive Officers

Terumo Announces Change of Executive Officers

TOKYO, JAPAN - February 9, 2017 - Terumo Corporation (TSE: 4543) hereby announces that it has resolved a change of its Executive Officers as follows.

1. Change of Executive Officers (As of April 1, 2017)

Name	New Title	Current Title
Hikaru Samejima	Senior Executive Officer President, Cardiac and Vascular Company Division President, Interventional Systems Division, Cardiac and Vascular Company	Senior Executive Officer Division President, Interventional Systems Division, Cardiac and Vascular Company
Masataka Haraguchi	Senior Executive Officer Branch Manager, Tokyo Branch	Executive Officer Branch Manager, Tokyo Branch
Takanori Shibazaki	Senior Executive Officer Regional Representative, China President and CEO, Terumo (China) Holdings Co., Ltd.	Executive Officer President and CEO, Terumo (China) Holdings Co., Ltd.
Kazuhisa Senshu	Executive Officer Chief Clinical and Regulatory Affairs Officer (CRAO)	Manager, Global-Headquarters, Clinical Development Dept. Manager, Global-Headquarters, Regulatory Affairs
Fumihisa Hirose	Executive Officer Senior Vice President, Cardiac and Vascular Company	Vice President, Global Marketing, Interventional Systems Division, Cardiac and Vascular Company
Paul Holbrook	Executive Officer Division President, Vascular Graft Division, Cardiac and Vascular Company President and CEO, Vascutek Ltd.	Division President, Vascular Graft Division, Cardiac and Vascular Company President and CEO, Vascutek Ltd.

Probir Das

Executive Officer Managing Director, Terumo India Private Limited

Managing Director, Terumo India Private Limited

About Terumo Corporation

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.

Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol , or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.

###